Genocea To Present At The Piper Jaffray 27th Annual Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a company overview at the upcoming Piper Jaffray 27th Annual Healthcare Conference on Tuesday, December 1, 2015 at 12:30 p.m. ET in New York, NY.